Waystar Holding Corp. (WAY) Peer Comparison

$25.72

$-0.04 (-0.16%)

As on 02-Sep-2026 16:00EDT

Market cap

$5,031 Mln

Revenue (TTM)

$1,206 Mln

P/E Ratio

37.5

P/B Ratio

1.2

Div. Yield

0 %

Edit

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Market cap ($ Mln)	5,031	3,544	20	1
Revenue ($ Mln)	1,206	573	6	3
Net Profit ($ Mln)	134.79	147.29	0.07	-16.79
Net Margin (%)	11.18	25.72	1.20	-671.01
RoE (%)	3.43	25.36	--	-86.93
Price to Earnings	37.49	25.73	--	--
Price-To-Book	1.22	5.88	1,802.81	0.12

Income Statement ($ Mln)

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Operating Revenue	1,205.74	572.56	2.05	2.50
Cost of Revenue	372.49	128.30	1.39	1.33
Gross Profit	751.12	380.84	0.66	0.03
Operating Expenses	557.49	437.75	0.93	14.44
Operating Profit (EBIT)	275.76	6.51	-0.27	-14.99
Other Income	0.00	0.00	--	0.00
Profit before Tax	195.08	14.06	-0.28	-16.26
Provision for Tax	60.29	-133.23	--	0.00
Profit after Tax (Net Income)	134.79	147.29	-0.28	-16.79
Minority Interest	0.00	0.00	--	0.00
Consolidated Profit	0.00	0.00	--	0.00

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Shareholder's Funds	3,986.24	613.43	-0.17	21.83
Minority Interest	0.00	0.00	--	0.00
Non-Current Liabilities	1,644.80	331.45	0.37	82.12
Current Liabilities	237.72	107.04	0.51	3.42
Total Liabilities	5,785.10	959.69	0.71	31.61

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Non-Current Assets	5,429.79	452.42	0.26	116.63
Current Assets	438.97	599.50	0.45	2.90
Total Assets	5,785.10	959.69	0.71	31.61
Total Debt*	1,481.72	311.48	0.35	0.40
Net Current Assets	201.25	0.00	-0.14	0.00

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Cash From Operating Activities	309.67	88.63	-0.21	-0.98
Cash Flow from Investing Activities	-680.90	-35.33	--	--
Cash from Financing Activities	243.45	282.07	0.16	0.16
Net Cash Inflow / Outflow	--	--	--	--

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
ROCE (%)	2.31	24.76	-2,636.14	-88.35
ROE (%)	3.43	25.36	170.10	-86.93
ROA (%)	2.46	11.89	-39.73	-82.49
EBIT Margin (%)	22.87	2.46	--	-574.02
Net Margin (%)	11.18	25.72	-13.81	-671.01
Cash Profit Margin (%)	0.00	0.00	--	0.00

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Revenue Growth (%)	19.23	33.96	0.00	--
EBIT Growth (%)	31.10	-29.77	--	--
Net Profit Growth (%)	56.83	434.21	0.00	-54.92
EPS Growth (%)	47.40	397.31	--	-2.88
Book Value Growth (%)	17.28	63.41	--	-95.05

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Price / Earnings	57.66	36.15	--	-0.04
Price / Book Value	1.67	9.95	--	0.02
Dividend Yield (%)	--	--	--	--
EV/EBITDA	20.18	113.70	--	0.06
Market Cap ($ Cr)	--	--	--	--

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Debt to Equity	0.36	0.00	-2.13	0.00
Short term debt to equity ratio	0.00	0.00	-0.75	0.02
Current Ratio	1.85	5.60	0.88	0.85
Quick Ratio	1.84	5.46	--	0.85
Interest Coverage	3.42	--	-31.30	-21.58

	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Debtors to sales (%)	15.42	17.21	--	57.49
Asset Turnover	0.22	0.46	2.88	0.12
Receivable days	55.08	53.89	--	33.47
Inventory Days	--	30.13	--	332.90
Payable days	51.57	23.32	80.44	202.97
Cash Conversion Cycle	--	60.70	--	163.39

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.